Immix Biopharma | Investor Presentation Deck | 64 slides · page 25 of 64
The slide uses a visual bridge to highlight a 67% improvement in response rates for NXC-201 compared to the average of the three competitors shown.
Deck · comparison_table · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 image 1/1 source-note 1/1 title 1/1
Components 5
primary bar-vertical logo-grid source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.